167 related articles for article (PubMed ID: 12392292)
1. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool.
Gebauer BS; Hricik DE; Atallah A; Bryan K; Riley J; Tary-Lehmann M; Greenspan NS; Dejelo C; Boehm BO; Hering BJ; Heeger PS
Am J Transplant; 2002 Oct; 2(9):857-66. PubMed ID: 12392292
[TBL] [Abstract][Full Text] [Related]
2. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
3. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.
Najafian N; Salama AD; Fedoseyeva EV; Benichou G; Sayegh MH
J Am Soc Nephrol; 2002 Jan; 13(1):252-259. PubMed ID: 11752045
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
5. Impact of preformed T-cell alloreactivity by means of donor-specific and panel of reactive T cells (PRT) ELISPOT in kidney transplantation.
Gandolfini I; Crespo E; Baweja M; Jarque M; Donadei C; Luque S; Montero N; Allesina A; Perin L; Maggiore U; Cravedi P; Bestard O
PLoS One; 2018; 13(7):e0200696. PubMed ID: 30059561
[TBL] [Abstract][Full Text] [Related]
6. Cross-validation of IFN-γ Elispot assay for measuring alloreactive memory/effector T cell responses in renal transplant recipients.
Bestard O; Crespo E; Stein M; Lúcia M; Roelen DL; de Vaal YJ; Hernandez-Fuentes MP; Chatenoud L; Wood KJ; Claas FH; Cruzado JM; Grinyó JM; Volk HD; Reinke P
Am J Transplant; 2013 Jul; 13(7):1880-90. PubMed ID: 23763435
[TBL] [Abstract][Full Text] [Related]
7. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes.
Heeger PS; Greenspan NS; Kuhlenschmidt S; Dejelo C; Hricik DE; Schulak JA; Tary-Lehmann M
J Immunol; 1999 Aug; 163(4):2267-75. PubMed ID: 10438971
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients.
Nickel P; Presber F; Bold G; Biti D; Schönemann C; Tullius SG; Volk HD; Reinke P
Transplantation; 2004 Dec; 78(11):1640-6. PubMed ID: 15591953
[TBL] [Abstract][Full Text] [Related]
9. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients.
Hricik DE; Rodriguez V; Riley J; Bryan K; Tary-Lehmann M; Greenspan N; Dejelo C; Schulak JA; Heeger PS
Am J Transplant; 2003 Jul; 3(7):878-84. PubMed ID: 12814480
[TBL] [Abstract][Full Text] [Related]
10. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
[TBL] [Abstract][Full Text] [Related]
11. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
12. Enzyme-Linked Immunosorbent Spot (ELISpot) monitoring of cytokine-producing cells for the prediction of acute rejection in renal transplant patients.
Mohammadi F; Solgi G; Tajik M; Ahmadpoor P; Nikoeinejad H; Einollahi B; Nazari B; Lessan-Pezeshki M; Amirzargar A
Eur Cytokine Netw; 2017 Sep; 28(3):93-101. PubMed ID: 29187340
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant donor-specific interferon-gamma ELISPOT assay predicts acute rejection episodes in renal transplant recipients.
Kim SH; Oh EJ; Kim MJ; Park YJ; Han K; Yang HJ; Kim JY; Choi BS; Yang CW; Kim YS; Bang BK
Transplant Proc; 2007 Dec; 39(10):3057-60. PubMed ID: 18089321
[TBL] [Abstract][Full Text] [Related]
14. Preferential benefit of antibody induction therapy in kidney recipients with high pretransplant frequencies of donor-reactive interferon-gamma enzyme-linked immunosorbent spots.
Augustine JJ; Poggio ED; Heeger PS; Hricik DE
Transplantation; 2008 Aug; 86(4):529-34. PubMed ID: 18724221
[TBL] [Abstract][Full Text] [Related]
15. T-cell immune monitoring by the ELISPOT assay for interferon gamma.
Augustine JJ; Hricik DE
Clin Chim Acta; 2012 Sep; 413(17-18):1359-63. PubMed ID: 22732764
[TBL] [Abstract][Full Text] [Related]
16. High-resolution characterization of cytokine-producing alloreactivity in naive and allograft-primed mice.
Matesic D; Lehmann PV; Heeger PS
Transplantation; 1998 Apr; 65(7):906-14. PubMed ID: 9565093
[TBL] [Abstract][Full Text] [Related]
17. Alloreactivity in renal transplant recipients with and without chronic allograft nephropathy.
Poggio ED; Clemente M; Riley J; Roddy M; Greenspan NS; Dejelo C; Najafian N; Sayegh MH; Hricik DE; Heeger PS
J Am Soc Nephrol; 2004 Jul; 15(7):1952-60. PubMed ID: 15213286
[TBL] [Abstract][Full Text] [Related]
18. Donor non-specific IFN-gamma production by primed alloreactive cells as a potential screening test to predict the alloimmune response.
Bendjelloul F; Desin TS; Shoker AS
Transpl Immunol; 2004 Jan; 12(2):167-76. PubMed ID: 14967315
[TBL] [Abstract][Full Text] [Related]
19. Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation.
Bestard O; Cruzado JM; Lucia M; Crespo E; Casis L; Sawitzki B; Vogt K; Cantarell C; Torras J; Melilli E; Mast R; Martinez-Castelao A; Gomà M; Reinke P; Volk HD; Grinyó JM
Kidney Int; 2013 Dec; 84(6):1226-36. PubMed ID: 23783240
[TBL] [Abstract][Full Text] [Related]
20. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
